Nisha Durand

Also affiliated with Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol”.

Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol

Neurosurgery Open(2023)10.1227/neuprac.0000000000000062

N/A

0.269DataRank · unranked

5 citations

Rawan Al‐kharboosh, Erin Twohy, Aleeshba Basil, Ewa Szymkiewicz, Abba C. Zubair +12 more

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group

Cytotherapy(2024)10.1016/j.jcyt.2024.05.024

N/A

0DataRank · unranked

10 citations

Jennifer N. Solomon, Fernanda Masri, Amanda A. Mack, Nisha Durand, Emmanuelle Cameau +12 more